210 related articles for article (PubMed ID: 32238435)
1. Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis.
Kritikos A; Poissy J; Croxatto A; Bochud PY; Pagani JL; Lamoth F
J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32238435
[TBL] [Abstract][Full Text] [Related]
2. The added value of (1,3)-β-D-glucan for the diagnosis of Invasive Candidiasis in ICU patients: a prospective cohort study.
Christner M; Abdennadher B; Wichmann D; Kluge S; Pepić A; Aepfelbacher M; Rohde H; Olearo F
Infection; 2024 Feb; 52(1):73-81. PubMed ID: 37322388
[TBL] [Abstract][Full Text] [Related]
3. β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study.
Hanson KE; Pfeiffer CD; Lease ED; Balch AH; Zaas AK; Perfect JR; Alexander BD
PLoS One; 2012; 7(8):e42282. PubMed ID: 22879929
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients.
Guitard J; Isnard F; Tabone MD; Antignac M; Brissot E; Senghor Y; Petit A; Leverger G; Hennequin C
J Infect; 2018 May; 76(5):483-488. PubMed ID: 29432826
[TBL] [Abstract][Full Text] [Related]
5. Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment.
Martínez-Jiménez MC; Muñoz P; Valerio M; Vena A; Guinea J; Bouza E
J Antimicrob Chemother; 2015 Nov; 70(11):3107-15. PubMed ID: 26311840
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Three β-Glucan Tests for the Diagnosis of Invasive Candidiasis in Intensive Care Units.
Kritikos A; Caruana G; Poissy J; Mamin A; Bachmann D; Pagani JL; Coste AT; Lamoth F
J Clin Microbiol; 2023 Feb; 61(2):e0169122. PubMed ID: 36700626
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of (1,3)-β-D-glucan alone or combined with traditional inflammatory markers in neonatal invasive candidiasis.
Guo J; Wu Y; Lai W; Lu W; Mu X
BMC Infect Dis; 2019 Aug; 19(1):716. PubMed ID: 31412796
[TBL] [Abstract][Full Text] [Related]
8. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
Bloos F; Held J; Schlattmann P; Brillinger N; Kurzai O; Cornely OA; Thomas-Rüddel D
Trials; 2018 Sep; 19(1):472. PubMed ID: 30180873
[TBL] [Abstract][Full Text] [Related]
9. Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery.
Prattes J; Hoenigl M; Rabensteiner J; Raggam RB; Prueller F; Zollner-Schwetz I; Valentin T; Hönigl K; Fruhwald S; Krause R
Mycoses; 2014 Nov; 57(11):679-86. PubMed ID: 25040144
[TBL] [Abstract][Full Text] [Related]
10. β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.
Martín-Mazuelos E; Loza A; Castro C; Macías D; Zakariya I; Saavedra P; Ruiz-Santana S; Marín E; León C
Intensive Care Med; 2015 Aug; 41(8):1424-32. PubMed ID: 26134359
[TBL] [Abstract][Full Text] [Related]
11. (1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study.
Posteraro B; Tumbarello M; De Pascale G; Liberto E; Vallecoccia MS; De Carolis E; Di Gravio V; Trecarichi EM; Sanguinetti M; Antonelli M
J Antimicrob Chemother; 2016 Aug; 71(8):2262-9. PubMed ID: 27125554
[TBL] [Abstract][Full Text] [Related]
12. Potential clinical and economic outcomes of active beta-D-glucan surveillance with preemptive therapy for invasive candidiasis at intensive care units: a decision model analysis.
Pang YK; Ip M; You JHS
Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):187-194. PubMed ID: 27686799
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.
León C; Ruiz-Santana S; Saavedra P; Castro C; Loza A; Zakariya I; Úbeda A; Parra M; Macías D; Tomás JI; Rezusta A; Rodríguez A; Gómez F; Martín-Mazuelos E;
Crit Care; 2016 May; 20(1):149. PubMed ID: 27181045
[TBL] [Abstract][Full Text] [Related]
14. Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study).
Ramos JT; Villar S; Bouza E; Bergon-Sendin E; Perez Rivilla A; Collados CT; Andreu M; Reyes CS; Campos-Herrero MI; de Heredia JL; Herrera MCL; Alonso PA; Pallás-Alonso CR; Cuenca-Estrella M;
J Clin Microbiol; 2017 Sep; 55(9):2752-2764. PubMed ID: 28659321
[TBL] [Abstract][Full Text] [Related]
15. The Presence of (1→3)-β-D-Glucan as Prognostic Marker in Patients After Major Abdominal Surgery.
White PL; Posso R; Parr C; Price JS; Finkelman M; Barnes RA
Clin Infect Dis; 2021 Oct; 73(7):e1415-e1422. PubMed ID: 32914187
[TBL] [Abstract][Full Text] [Related]
16. T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study.
Muñoz P; Vena A; Machado M; Gioia F; Martínez-Jiménez MC; Gómez E; Origüen J; Orellana MÁ; López-Medrano F; Fernández-Ruiz M; Merino P; González-Romo F; Frías I; Pérez-Granda MJ; Aguado JM; Fortún J; Bouza E;
J Antimicrob Chemother; 2018 Mar; 73(suppl_4):iv6-iv12. PubMed ID: 29608751
[TBL] [Abstract][Full Text] [Related]
17. (1 → 3)-β-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial.
Bloos F; Held J; Kluge S; Simon P; Kogelmann K; de Heer G; Kuhn SO; Jarczak D; Motsch J; Hempel G; Weiler N; Weyland A; Drüner M; Gründling M; Meybohm P; Richter D; Jaschinski U; Moerer O; Günther U; Schädler D; Weiss R; Putensen C; Castellanos I; Kurzai O; Schlattmann P; Cornely OA; Bauer M; Thomas-Rüddel D;
Intensive Care Med; 2022 Jul; 48(7):865-875. PubMed ID: 35708758
[TBL] [Abstract][Full Text] [Related]
18. Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study.
Mikulska M; Furfaro E; Magnasco L; Codda G; Giacobbe DR; Dentone C; Vena A; Marchese A; Bassetti M
Clin Microbiol Infect; 2022 Aug; 28(8):1154.e1-1154.e3. PubMed ID: 35283316
[TBL] [Abstract][Full Text] [Related]
19. Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions.
León C; Ruiz-Santana S; Saavedra P; Castro C; Ubeda A; Loza A; Martín-Mazuelos E; Blanco A; Jerez V; Ballús J; Alvarez-Rocha L; Utande-Vázquez A; Fariñas O
Intensive Care Med; 2012 Aug; 38(8):1315-25. PubMed ID: 22752333
[TBL] [Abstract][Full Text] [Related]
20. β-(1→3)-D-glucan- and mannan-guided early termination of antifungal therapy in ICU patients: a randomized controlled study.
Erb T; Mihai S; Strauß R; Herbst L; Castellanos I; Diesch K; Cipa F; Bihlmaier K; Lang A-K; Ganslmayer M; Willam C; Bremer F; Fürst J; Beyer C; Bogdan C; Rath A; Held J
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0072523. PubMed ID: 37823695
[No Abstract] [Full Text] [Related]
[Next] [New Search]
